Literature DB >> 6466703

Metabolic energy is required in human platelets at any stage during optical aggregation and secretion.

A J Verhoeven, M E Mommersteeg, J W Akkerman.   

Abstract

The relationship between metabolic energy and platelet aggregation and secretion was investigated by sudden exhaustion of the cell energy content after these platelet responses had been initiated. In normal platelets, optical aggregation was at any stage susceptible to energy exhaustion, whereas single platelet disappearance and secretion were hardly affected. Prelowering the platelet energy content, while preserving the adenylate energy charge, made both optical aggregation and the secretion from dense, alpha- and acid hydrolase-containing granules susceptible to energy exhaustion, but single platelet disappearance was not affected. Complete arrest of secretion occurred when the energy content had fallen below 3-3.5 mumol ATP equivalents (ATPeq)/10(11) platelets, while optical aggregation was interrupted below 2-2.5 mumol ATPeq/10(11) platelets. At any stage of optical aggregation and the three secretion responses, the dependence on energy remained the same, indicating a tight coupling between these functions and metabolic energy, which held during the entire responses.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6466703     DOI: 10.1016/0304-4165(84)90402-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  Superoxide Dismutase 2 is dispensable for platelet function.

Authors:  Trevor P Fidler; Jesse W Rowley; Claudia Araujo; Luc H Boudreau; Alex Marti; Rhonda Souvenir; Kali Dale; Eric Boilard; Andrew S Weyrich; E Dale Abel
Journal:  Thromb Haemost       Date:  2017-08-03       Impact factor: 5.249

2.  Exposure of ligand-binding sites on platelet integrin alpha IIB/beta 3 by phosphorylation of the beta 3 subunit.

Authors:  G van Willigen; I Hers; G Gorter; J W Akkerman
Journal:  Biochem J       Date:  1996-03-15       Impact factor: 3.857

3.  4,4'-Di-isothiocyanatostilbene-2,2'-disulphonic acid ('DIDS') activates protein kinase C and Na+/H+ exchange in human platelets via alpha 2A-adrenergic receptors.

Authors:  R Nieuwland; G Van Willigen; J W Akkerman
Journal:  Biochem J       Date:  1993-07-15       Impact factor: 3.857

4.  PAF-acether (1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphocholine)-induced fibrinogen binding to platelets depends on metabolic energy.

Authors:  E Kloprogge; P Hasselaar; J W Akkerman
Journal:  Biochem J       Date:  1986-09-15       Impact factor: 3.857

5.  Regulation of the receptor for platelet-activating factor on human platelets.

Authors:  J A Burgers; J W Akkerman
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

6.  Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.

Authors:  J J Zwaginga; H A Koomans; J J Sixma; T J Rabelink
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

7.  The energetics of early platelet responses. Energy consumption during shape change and aggregation with special reference to protein phosphorylation and the polyphosphoinositide cycle.

Authors:  A J Verhoeven; G Gorter; M E Mommersteeg; J W Akkerman
Journal:  Biochem J       Date:  1985-06-01       Impact factor: 3.857

8.  Increased platelet deposition on atherosclerotic coronary arteries.

Authors:  G H van Zanten; S de Graaf; P J Slootweg; H F Heijnen; T M Connolly; P G de Groot; J J Sixma
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

9.  Essential synergy between Ca2+ and guanine nucleotides in exocytotic secretion from permeabilized rat mast cells.

Authors:  T W Howell; S Cockcroft; B D Gomperts
Journal:  J Cell Biol       Date:  1987-07       Impact factor: 10.539

10.  Glycoprotein Ib activation by thrombin stimulates the energy metabolism in human platelets.

Authors:  Norma Corona de la Peña; Manuel Gutiérrez-Aguilar; Ileana Hernández-Reséndiz; Álvaro Marín-Hernández; Sara Rodríguez-Enríquez
Journal:  PLoS One       Date:  2017-08-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.